Argentina vs Paraguay: Prevalence rate of hypertension in men aged 30-79
Argentina
54
in 2019
Paraguay
61.6
in 2019
Argentina rank
4th
Paraguay rank
1st
Prevalence rate of hypertension in men aged 30-79 over time
- Argentina
- Paraguay
How they compare
Paraguay currently reports 61.6 against 54 in Argentina, a difference of 7.6.
That makes Paraguay's figure about 1.1 times Argentina's.
Across all 30 years both countries report, Paraguay has been ahead every year.
Argentina ranks 4th and Paraguay ranks 1st of 195 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 42.14 | 53.75 | 11.61 | Paraguay |
| 2000s | 46.59 | 58.69 | 12.1 | Paraguay |
| 2010s | 51.56 | 61.24 | 9.68 | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Argentina or Paraguay?
- Paraguay, at 61.6 against 54 in Argentina as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Argentina and Paraguay?
- 7.6, with Paraguay ahead.
- How many years of comparable data are there for Argentina and Paraguay?
- 30 years are reported by both, from 1990 to 2019.
- How do Argentina and Paraguay rank globally for prevalence rate of hypertension in men aged 30-79?
- Argentina ranks 4th and Paraguay ranks 1st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.